FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its
Read MoreThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its
Read MoreThe FDA has not informed Moderna of any issues related to the vaccine's safety, efficacy or quality that would prevent
Read MoreNow is the time to diversify your portfolio beyond flashy tech plays, according to Sarat Sethi, portfolio manager of Douglas C.
Read MoreA major car stock and a pharmaceutical giant were part of the early morning analyst chatter Monday. Source link
Read MoreOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600
Read More"In my opinion, it always comes down to individual stock selection," says David Sekera, naming shares that look undervalued right
Read MoreHere are the most important news items that investors need to start their trading day. Source link
Read MoreThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MorePublic health officials are urging eligible Americans to take all three shots so the nation can avoid another "tripledemic" of
Read More